Overactive Bladder (OAB) Bionic Drug Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Overactive Bladder (OAB) Bionic Drug in Global, including the following market information:
Global Overactive Bladder (OAB) Bionic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Overactive Bladder (OAB) Bionic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anticholinergics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Overactive Bladder (OAB) Bionic Drug include AbbVie, Astellas Pharma, Pfizer, Teva, Johnson & Johnson, Kyorin Pharmaceutical, Tianjin Pacific Pharmaceutical Co., Ltd., Nanjing Meirui Pharma Co., Ltd. and DIKANG and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Overactive Bladder (OAB) Bionic Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Overactive Bladder (OAB) Bionic Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Overactive Bladder (OAB) Bionic Drug Market Segment Percentages, by Type, 2021 (%)
Global Overactive Bladder (OAB) Bionic Drug Market Segment Percentages, by Application, 2021 (%)
Global Overactive Bladder (OAB) Bionic Drug Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Overactive Bladder (OAB) Bionic Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Overactive Bladder (OAB) Bionic Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Overactive Bladder (OAB) Bionic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Overactive Bladder (OAB) Bionic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anticholinergics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Overactive Bladder (OAB) Bionic Drug include AbbVie, Astellas Pharma, Pfizer, Teva, Johnson & Johnson, Kyorin Pharmaceutical, Tianjin Pacific Pharmaceutical Co., Ltd., Nanjing Meirui Pharma Co., Ltd. and DIKANG and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Overactive Bladder (OAB) Bionic Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Overactive Bladder (OAB) Bionic Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Overactive Bladder (OAB) Bionic Drug Market Segment Percentages, by Type, 2021 (%)
- Anticholinergics
- Mirabegron
- Botox
- Others
Global Overactive Bladder (OAB) Bionic Drug Market Segment Percentages, by Application, 2021 (%)
- Idiopathic Overactive Bladder
- Neurogenic Overactive Bladder
Global Overactive Bladder (OAB) Bionic Drug Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Overactive Bladder (OAB) Bionic Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Overactive Bladder (OAB) Bionic Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AbbVie
- Astellas Pharma
- Pfizer
- Teva
- Johnson & Johnson
- Kyorin Pharmaceutical
- Tianjin Pacific Pharmaceutical Co., Ltd.
- Nanjing Meirui Pharma Co., Ltd.
- DIKANG
- Nanjing Zenkom Pharmaceutical Co., Ltd.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Overactive Bladder (OAB) Bionic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Overactive Bladder (OAB) Bionic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL OVERACTIVE BLADDER (OAB) BIONIC DRUG OVERALL MARKET SIZE
2.1 Global Overactive Bladder (OAB) Bionic Drug Market Size: 2021 VS 2028
2.2 Global Overactive Bladder (OAB) Bionic Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Overactive Bladder (OAB) Bionic Drug Players in Global Market
3.2 Top Global Overactive Bladder (OAB) Bionic Drug Companies Ranked by Revenue
3.3 Global Overactive Bladder (OAB) Bionic Drug Revenue by Companies
3.4 Top 3 and Top 5 Overactive Bladder (OAB) Bionic Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Overactive Bladder (OAB) Bionic Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Overactive Bladder (OAB) Bionic Drug Players in Global Market
3.6.1 List of Global Tier 1 Overactive Bladder (OAB) Bionic Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Overactive Bladder (OAB) Bionic Drug Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Overactive Bladder (OAB) Bionic Drug Market Size Markets, 2021 & 2028
4.1.2 Anticholinergics
4.1.3 Mirabegron
4.1.4 Botox
4.1.5 Others
4.2 By Type - Global Overactive Bladder (OAB) Bionic Drug Revenue & Forecasts
4.2.1 By Type - Global Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2022
4.2.2 By Type - Global Overactive Bladder (OAB) Bionic Drug Revenue, 2023-2028
4.2.3 By Type - Global Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Overactive Bladder (OAB) Bionic Drug Market Size, 2021 & 2028
5.1.2 Idiopathic Overactive Bladder
5.1.3 Neurogenic Overactive Bladder
5.2 By Application - Global Overactive Bladder (OAB) Bionic Drug Revenue & Forecasts
5.2.1 By Application - Global Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2022
5.2.2 By Application - Global Overactive Bladder (OAB) Bionic Drug Revenue, 2023-2028
5.2.3 By Application - Global Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Overactive Bladder (OAB) Bionic Drug Market Size, 2021 & 2028
6.2 By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue & Forecasts
6.2.1 By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2022
6.2.2 By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue, 2023-2028
6.2.3 By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2028
6.3.2 US Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.3.3 Canada Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.3.4 Mexico Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2028
6.4.2 Germany Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4.3 France Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4.4 U.K. Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4.5 Italy Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4.6 Russia Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4.7 Nordic Countries Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4.8 Benelux Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2028
6.5.2 China Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.5.3 Japan Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.5.4 South Korea Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.5.5 Southeast Asia Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.5.6 India Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2028
6.6.2 Brazil Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.6.3 Argentina Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2028
6.7.2 Turkey Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.7.3 Israel Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.7.5 UAE Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.1.4 AbbVie Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.1.5 AbbVie Key News
7.2 Astellas Pharma
7.2.1 Astellas Pharma Corporate Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.2.4 Astellas Pharma Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.2.5 Astellas Pharma Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.3.4 Pfizer Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.4.4 Teva Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.4.5 Teva Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.5.4 Johnson & Johnson Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Kyorin Pharmaceutical
7.6.1 Kyorin Pharmaceutical Corporate Summary
7.6.2 Kyorin Pharmaceutical Business Overview
7.6.3 Kyorin Pharmaceutical Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.6.4 Kyorin Pharmaceutical Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.6.5 Kyorin Pharmaceutical Key News
7.7 Tianjin Pacific Pharmaceutical Co., Ltd.
7.7.1 Tianjin Pacific Pharmaceutical Co., Ltd. Corporate Summary
7.7.2 Tianjin Pacific Pharmaceutical Co., Ltd. Business Overview
7.7.3 Tianjin Pacific Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.7.4 Tianjin Pacific Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.7.5 Tianjin Pacific Pharmaceutical Co., Ltd. Key News
7.8 Nanjing Meirui Pharma Co., Ltd.
7.8.1 Nanjing Meirui Pharma Co., Ltd. Corporate Summary
7.8.2 Nanjing Meirui Pharma Co., Ltd. Business Overview
7.8.3 Nanjing Meirui Pharma Co., Ltd. Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.8.4 Nanjing Meirui Pharma Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.8.5 Nanjing Meirui Pharma Co., Ltd. Key News
7.9 DIKANG
7.9.1 DIKANG Corporate Summary
7.9.2 DIKANG Business Overview
7.9.3 DIKANG Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.9.4 DIKANG Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.9.5 DIKANG Key News
7.10 Nanjing Zenkom Pharmaceutical Co., Ltd.
7.10.1 Nanjing Zenkom Pharmaceutical Co., Ltd. Corporate Summary
7.10.2 Nanjing Zenkom Pharmaceutical Co., Ltd. Business Overview
7.10.3 Nanjing Zenkom Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.10.4 Nanjing Zenkom Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.10.5 Nanjing Zenkom Pharmaceutical Co., Ltd. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Overactive Bladder (OAB) Bionic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Overactive Bladder (OAB) Bionic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL OVERACTIVE BLADDER (OAB) BIONIC DRUG OVERALL MARKET SIZE
2.1 Global Overactive Bladder (OAB) Bionic Drug Market Size: 2021 VS 2028
2.2 Global Overactive Bladder (OAB) Bionic Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Overactive Bladder (OAB) Bionic Drug Players in Global Market
3.2 Top Global Overactive Bladder (OAB) Bionic Drug Companies Ranked by Revenue
3.3 Global Overactive Bladder (OAB) Bionic Drug Revenue by Companies
3.4 Top 3 and Top 5 Overactive Bladder (OAB) Bionic Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Overactive Bladder (OAB) Bionic Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Overactive Bladder (OAB) Bionic Drug Players in Global Market
3.6.1 List of Global Tier 1 Overactive Bladder (OAB) Bionic Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Overactive Bladder (OAB) Bionic Drug Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Overactive Bladder (OAB) Bionic Drug Market Size Markets, 2021 & 2028
4.1.2 Anticholinergics
4.1.3 Mirabegron
4.1.4 Botox
4.1.5 Others
4.2 By Type - Global Overactive Bladder (OAB) Bionic Drug Revenue & Forecasts
4.2.1 By Type - Global Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2022
4.2.2 By Type - Global Overactive Bladder (OAB) Bionic Drug Revenue, 2023-2028
4.2.3 By Type - Global Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Overactive Bladder (OAB) Bionic Drug Market Size, 2021 & 2028
5.1.2 Idiopathic Overactive Bladder
5.1.3 Neurogenic Overactive Bladder
5.2 By Application - Global Overactive Bladder (OAB) Bionic Drug Revenue & Forecasts
5.2.1 By Application - Global Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2022
5.2.2 By Application - Global Overactive Bladder (OAB) Bionic Drug Revenue, 2023-2028
5.2.3 By Application - Global Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Overactive Bladder (OAB) Bionic Drug Market Size, 2021 & 2028
6.2 By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue & Forecasts
6.2.1 By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2022
6.2.2 By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue, 2023-2028
6.2.3 By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2028
6.3.2 US Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.3.3 Canada Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.3.4 Mexico Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2028
6.4.2 Germany Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4.3 France Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4.4 U.K. Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4.5 Italy Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4.6 Russia Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4.7 Nordic Countries Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.4.8 Benelux Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2028
6.5.2 China Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.5.3 Japan Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.5.4 South Korea Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.5.5 Southeast Asia Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.5.6 India Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2028
6.6.2 Brazil Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.6.3 Argentina Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2028
6.7.2 Turkey Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.7.3 Israel Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
6.7.5 UAE Overactive Bladder (OAB) Bionic Drug Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.1.4 AbbVie Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.1.5 AbbVie Key News
7.2 Astellas Pharma
7.2.1 Astellas Pharma Corporate Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.2.4 Astellas Pharma Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.2.5 Astellas Pharma Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.3.4 Pfizer Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.4.4 Teva Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.4.5 Teva Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.5.4 Johnson & Johnson Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Kyorin Pharmaceutical
7.6.1 Kyorin Pharmaceutical Corporate Summary
7.6.2 Kyorin Pharmaceutical Business Overview
7.6.3 Kyorin Pharmaceutical Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.6.4 Kyorin Pharmaceutical Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.6.5 Kyorin Pharmaceutical Key News
7.7 Tianjin Pacific Pharmaceutical Co., Ltd.
7.7.1 Tianjin Pacific Pharmaceutical Co., Ltd. Corporate Summary
7.7.2 Tianjin Pacific Pharmaceutical Co., Ltd. Business Overview
7.7.3 Tianjin Pacific Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.7.4 Tianjin Pacific Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.7.5 Tianjin Pacific Pharmaceutical Co., Ltd. Key News
7.8 Nanjing Meirui Pharma Co., Ltd.
7.8.1 Nanjing Meirui Pharma Co., Ltd. Corporate Summary
7.8.2 Nanjing Meirui Pharma Co., Ltd. Business Overview
7.8.3 Nanjing Meirui Pharma Co., Ltd. Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.8.4 Nanjing Meirui Pharma Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.8.5 Nanjing Meirui Pharma Co., Ltd. Key News
7.9 DIKANG
7.9.1 DIKANG Corporate Summary
7.9.2 DIKANG Business Overview
7.9.3 DIKANG Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.9.4 DIKANG Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.9.5 DIKANG Key News
7.10 Nanjing Zenkom Pharmaceutical Co., Ltd.
7.10.1 Nanjing Zenkom Pharmaceutical Co., Ltd. Corporate Summary
7.10.2 Nanjing Zenkom Pharmaceutical Co., Ltd. Business Overview
7.10.3 Nanjing Zenkom Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Major Product Offerings
7.10.4 Nanjing Zenkom Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue in Global Market (2017-2022)
7.10.5 Nanjing Zenkom Pharmaceutical Co., Ltd. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Overactive Bladder (OAB) Bionic Drug Market Opportunities & Trends in Global Market
Table 2. Overactive Bladder (OAB) Bionic Drug Market Drivers in Global Market
Table 3. Overactive Bladder (OAB) Bionic Drug Market Restraints in Global Market
Table 4. Key Players of Overactive Bladder (OAB) Bionic Drug in Global Market
Table 5. Top Overactive Bladder (OAB) Bionic Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Overactive Bladder (OAB) Bionic Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Overactive Bladder (OAB) Bionic Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Overactive Bladder (OAB) Bionic Drug Product Type
Table 9. List of Global Tier 1 Overactive Bladder (OAB) Bionic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Overactive Bladder (OAB) Bionic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Overactive Bladder (OAB) Bionic Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Overactive Bladder (OAB) Bionic Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Overactive Bladder (OAB) Bionic Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Overactive Bladder (OAB) Bionic Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 32. AbbVie Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 33. Astellas Pharma Corporate Summary
Table 34. Astellas Pharma Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 35. Astellas Pharma Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 38. Pfizer Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 39. Teva Corporate Summary
Table 40. Teva Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 41. Teva Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 44. Johnson & Johnson Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 45. Kyorin Pharmaceutical Corporate Summary
Table 46. Kyorin Pharmaceutical Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 47. Kyorin Pharmaceutical Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 48. Tianjin Pacific Pharmaceutical Co., Ltd. Corporate Summary
Table 49. Tianjin Pacific Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 50. Tianjin Pacific Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 51. Nanjing Meirui Pharma Co., Ltd. Corporate Summary
Table 52. Nanjing Meirui Pharma Co., Ltd. Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 53. Nanjing Meirui Pharma Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 54. DIKANG Corporate Summary
Table 55. DIKANG Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 56. DIKANG Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 57. Nanjing Zenkom Pharmaceutical Co., Ltd. Corporate Summary
Table 58. Nanjing Zenkom Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 59. Nanjing Zenkom Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 1. Overactive Bladder (OAB) Bionic Drug Market Opportunities & Trends in Global Market
Table 2. Overactive Bladder (OAB) Bionic Drug Market Drivers in Global Market
Table 3. Overactive Bladder (OAB) Bionic Drug Market Restraints in Global Market
Table 4. Key Players of Overactive Bladder (OAB) Bionic Drug in Global Market
Table 5. Top Overactive Bladder (OAB) Bionic Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Overactive Bladder (OAB) Bionic Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Overactive Bladder (OAB) Bionic Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Overactive Bladder (OAB) Bionic Drug Product Type
Table 9. List of Global Tier 1 Overactive Bladder (OAB) Bionic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Overactive Bladder (OAB) Bionic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Overactive Bladder (OAB) Bionic Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Overactive Bladder (OAB) Bionic Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Overactive Bladder (OAB) Bionic Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Overactive Bladder (OAB) Bionic Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 32. AbbVie Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 33. Astellas Pharma Corporate Summary
Table 34. Astellas Pharma Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 35. Astellas Pharma Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 38. Pfizer Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 39. Teva Corporate Summary
Table 40. Teva Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 41. Teva Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 44. Johnson & Johnson Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 45. Kyorin Pharmaceutical Corporate Summary
Table 46. Kyorin Pharmaceutical Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 47. Kyorin Pharmaceutical Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 48. Tianjin Pacific Pharmaceutical Co., Ltd. Corporate Summary
Table 49. Tianjin Pacific Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 50. Tianjin Pacific Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 51. Nanjing Meirui Pharma Co., Ltd. Corporate Summary
Table 52. Nanjing Meirui Pharma Co., Ltd. Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 53. Nanjing Meirui Pharma Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 54. DIKANG Corporate Summary
Table 55. DIKANG Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 56. DIKANG Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
Table 57. Nanjing Zenkom Pharmaceutical Co., Ltd. Corporate Summary
Table 58. Nanjing Zenkom Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Product Offerings
Table 59. Nanjing Zenkom Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Overactive Bladder (OAB) Bionic Drug Segment by Type in 2021
Figure 2. Overactive Bladder (OAB) Bionic Drug Segment by Application in 2021
Figure 3. Global Overactive Bladder (OAB) Bionic Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Overactive Bladder (OAB) Bionic Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Overactive Bladder (OAB) Bionic Drug Revenue in 2021
Figure 8. By Type - Global Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 12. US Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 16. Germany Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 24. China Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Astellas Pharma Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Kyorin Pharmaceutical Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Tianjin Pacific Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Nanjing Meirui Pharma Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. DIKANG Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Nanjing Zenkom Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Overactive Bladder (OAB) Bionic Drug Segment by Type in 2021
Figure 2. Overactive Bladder (OAB) Bionic Drug Segment by Application in 2021
Figure 3. Global Overactive Bladder (OAB) Bionic Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Overactive Bladder (OAB) Bionic Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Overactive Bladder (OAB) Bionic Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Overactive Bladder (OAB) Bionic Drug Revenue in 2021
Figure 8. By Type - Global Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 12. US Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 16. Germany Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 24. China Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Overactive Bladder (OAB) Bionic Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Overactive Bladder (OAB) Bionic Drug Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Astellas Pharma Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Kyorin Pharmaceutical Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Tianjin Pacific Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Nanjing Meirui Pharma Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. DIKANG Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Nanjing Zenkom Pharmaceutical Co., Ltd. Overactive Bladder (OAB) Bionic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
